BioPharm International
August 01, 2009
Issue PDF
22
8
Pfizer Tackles Lean and Six Sigma
August 01, 2009
Features
22
8
A better method for trend analysis than CUSUM and control charts.
August 01, 2009
Features
22
8
Select the best approach to determine critical quality attributes.
August 01, 2009
From the Editor
22
8
Perhaps the best way to regulate drugs is to regulate them not conservatively or liberally, but effectively.
August 01, 2009
Manufacturing Economics Series
22
8
A case study in capturing indirect costs and benefits.
August 01, 2009
Cover
22
8
Enabling site-wide process efficiency.
August 01, 2009
Final Word
22
8
The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable.
August 01, 2009
Outsourcing Insights
22
8
Contract research, development, and manufacturing organizations betting on a comeback in venture capital financing will have a long wait.
August 01, 2009
Regulatory Beat
22
8
Pressures to reduce healthcare spending generates proposals to spur competition, cut costs.
August 01, 2009
Expression Systems
22
8
Companies often wait for a critical mass before adopting new technologies. But if no one takes the risk, critical mass will never be reached.